Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Enovis Corp (ENOV)

Enovis Corp (ENOV)
34.50 x 1 41.56 x 2
Post-market by (Cboe BZX)
35.10 -0.02 (-0.06%) 04/25/25 [NYSE]
34.50 x 1 41.56 x 2
Post-market 35.10 unch (unch) 16:00 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
34.75
Day High
35.53
Open 34.97
Previous Close 35.12 35.12
Volume 890,600 890,600
Avg Vol 1,017,980 1,017,980
Stochastic %K 84.80% 84.80%
Weighted Alpha -37.16 -37.16
5-Day Change +3.14 (+9.82%) +3.14 (+9.82%)
52-Week Range 29.32 - 56.43 29.32 - 56.43
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,857,723
  • Shares Outstanding, K 57,108
  • Annual Sales, $ 2,108 M
  • Annual Income, $ -825,490 K
  • EBIT $ 35 M
  • EBITDA $ 970 M
  • 60-Month Beta 1.86
  • Price/Sales 0.95
  • Price/Cash Flow 1.83
  • Price/Book 0.78

Options Overview Details

View History
  • Implied Volatility 64.07% ( +2.90%)
  • Historical Volatility 58.49%
  • IV Percentile 92%
  • IV Rank 70.10%
  • IV High 82.34% on 04/07/25
  • IV Low 21.22% on 05/16/24
  • Put/Call Vol Ratio 999.99
  • Today's Volume 15
  • Volume Avg (30-Day) 401
  • Put/Call OI Ratio 3.81
  • Today's Open Interest 6,209
  • Open Int (30-Day) 6,067

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.74
  • Number of Estimates 4
  • High Estimate 0.76
  • Low Estimate 0.73
  • Prior Year 0.50
  • Growth Rate Est. (year over year) +48.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.32 +19.73%
on 04/09/25
Period Open: 39.40
39.75 -11.70%
on 03/26/25
-4.30 (-10.91%)
since 03/25/25
3-Month
29.32 +19.73%
on 04/09/25
Period Open: 47.79
49.38 -28.92%
on 01/27/25
-12.69 (-26.55%)
since 01/24/25
52-Week
29.32 +19.73%
on 04/09/25
Period Open: 55.10
56.43 -37.80%
on 05/01/24
-20.00 (-36.30%)
since 04/25/24

Most Recent Stories

More News
Reasons to Sell ENOV and 1 Stock to Buy Instead

Reasons to Sell ENOV and 1 Stock to Buy Instead

ENOV : 35.10 (-0.06%)
TTD : 53.97 (+1.31%)
Enovis to Host First Quarter 2025 Results Conference Call on May 8th

ENOV : 35.10 (-0.06%)
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About

1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About

ENOV : 35.10 (-0.06%)
BBCP : 6.26 (+1.62%)
DECK : 109.19 (-1.32%)
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4

Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4

INSP : 159.06 (+0.54%)
ENOV : 35.10 (-0.06%)
ITGR : 123.41 (+1.61%)
STAA : 18.03 (+0.84%)
HAE : 62.51 (+0.95%)
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest

INSP : 159.06 (+0.54%)
ENOV : 35.10 (-0.06%)
ITGR : 123.41 (+1.61%)
GMED : 72.80 (-0.37%)
HAE : 62.51 (+0.95%)
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment

Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment

INSP : 159.06 (+0.54%)
ENOV : 35.10 (-0.06%)
ITGR : 123.41 (+1.61%)
BLCO : 13.73 (-1.15%)
HAE : 62.51 (+0.95%)
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer

ENOV : 35.10 (-0.06%)
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down

ENOV : 35.10 (-0.06%)
ASTH : 30.60 (-2.55%)
ENSG : 126.04 (+0.94%)
Enovisâ„¢ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025

ENOV : 35.10 (-0.06%)
3 Stocks Under $50 in the Doghouse

3 Stocks Under $50 in the Doghouse

ENOV : 35.10 (-0.06%)
WEN : 12.78 (-0.39%)
LXFR : 10.02 (-0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.

See More

Key Turning Points

3rd Resistance Point 36.28
2nd Resistance Point 35.91
1st Resistance Point 35.50
Last Price 35.10
1st Support Level 34.72
2nd Support Level 34.35
3rd Support Level 33.94

See More

52-Week High 56.43
Fibonacci 61.8% 46.07
Fibonacci 50% 42.87
Fibonacci 38.2% 39.67
Last Price 35.10
52-Week Low 29.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective